The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 07, 2020
Filed:
Mar. 25, 2014
Applicant:
Faron Pharmaceuticals Oy, Turku, FI;
Inventors:
Assignee:
FARON PHARMACEUTICALS OY, Turku, FI;
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); C12N 15/113 (2010.01); C07K 16/28 (2006.01); A61K 31/58 (2006.01); A61K 35/15 (2015.01); A61K 38/17 (2006.01); A61K 38/20 (2006.01); C12N 15/115 (2010.01); C12Q 1/6883 (2018.01); C12Q 1/6886 (2018.01);
U.S. Cl.
CPC ...
C12N 15/1138 (2013.01); A61K 31/58 (2013.01); A61K 35/15 (2013.01); A61K 38/17 (2013.01); A61K 38/202 (2013.01); A61K 38/2026 (2013.01); C07K 16/28 (2013.01); C12N 15/115 (2013.01); C12Q 1/6883 (2013.01); C12Q 1/6886 (2013.01);
Abstract
The invention relates to a novel cell derived from the human body, where said cell comprises a Clever-1 receptor; to a method for affecting the immune system of an individual and for treatment of diseases or conditions related to the function of the immune system and to methods for screening of cancer patients that may respond to an anti-Clever-1 therapy or for diagnosing of a pregnancy complication or for estimating the risk of such complication in a pregnant woman.